Synaptogenix increases psilocybin stake with PsygaBio

Biopharmaceutical company Synaptogenix, Inc. (Nasdaq: SNPX) has increased its stake in the psilocybin drug discovery company PsygaBio through its previously announced partnership with Cannasoul...